Asset 2123.png


Developing a pipeline of novel candidates

focused on unmet medical needs for patients

Each disease area and drug program in our pipeline takes us one step closer to transforming preclinical R&D using computational biology, real-world evidence data and gene editing to discover and validate novel therapies more efficiently than traditional approaches to deliver better medicines, faster.